CD40LG and neoplasm: One vector, Ad5/3-hTERT-E1A-hCD40L, has been modified in several ways: it contains a chimeric Ad5/3 capsid for enhanced tumor transduction, a human telomerase reverse transcriptase (hTERT) promoter for tumor selectivity, and human CD40L for increased costimulation.